4d Molecular Therapeutics In shares owned by Acadian Asset Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in 4d Molecular Therapeutics In by Acadian Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $478k | 55k | 8.68 |
| 2025-06-30 | $1.2M | 331k | 3.71 |
| 2025-03-31 | $1.3M | 401k | 3.22 |
| 2024-12-31 | $185k | 33k | 5.56 |
| 2022-09-30 | $454k | 57k | 8.02 |
| 2022-06-30 | $663k | 95k | 6.98 |